First Trust Nasdaq PharmaceuFTXHETF
13F holders, Q2 2025 (June 30)18holders −2
1new positions
3sold out
$25.62avg. 13F price*
At the end of Q2 2025, 18 institutions reported holding First Trust Nasdaq Pharmaceu (FTXH) in their 13F filings, down 2 from Q1 2025. 1 opened new positions and 3 sold out. The largest holders were LPL Financial LLC ($2.8M), Goldman Sachs Group Inc. ($825K) and Envestnet Asset Management Inc. ($455K).
- Company
- First Trust Nasdaq Pharmaceu
- CUSIP
- 33738R837
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $57K |
| Exits | 3 | $660K |
All 13F filers, Q1 2025 → Q2 2025: 24,278 shares bought and 30,045 shares sold, net −5,767 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 18 holders
| LPL Financial LLC | 0.00% | Add +3.9% | 109,007 | $2.8M |
| Goldman Sachs Group Inc. | 0.00% | Add +65.3% | 32,186 | $825K |
| Envestnet Asset Management Inc. | 0.00% | Reduce -5.5% | 17,765 | $455K |
| Cambridge Investment Research Advisors, Inc. | 0.00% | Add +2.5% | 16,986 | $435K |
| Ameritas Investment Partners, Inc. | 0.01% | Add +2.5% | 15,711 | $403K |
| WMG Financial Advisors, LLC | 0.10% | Reduce -16.1% | 10,820 | $277K |
| Debussy Capital Management LP | 0.04% | Reduce -15.4% | 9,406 | $241K |
| Bank of Montreal | 0.00% | Add +68.2% | 8,221 | $211K |
| Morgan Stanley | 0.00% | Add +0.0% | 5,916 | $152K |
| UBS Group AG | 0.00% | Add +37.5% | 3,996 | $102K |
| Osaic Holdings, Inc. | 0.00% | Reduce -12.0% | 3,297 | $84K |
| Steward Partners Investment Advisory, LLC | 0.00% | Reduce -20.1% | 2,726 | $70K |
| Raymond James Financial Inc. | 0.00% | New | 2,225 | $57K |
| Lanark Financial, Inc. | 0.00% | Reduce -7.3% | 996 | $25K |
| Harbour Investments, Inc. | 0.00% | No change | 836 | $21K |
| Asset Dedication, LLC | 0.00% | No change | 593 | $15K |
| Capital Investment Advisory Services, LLC | 0.00% | No change | 450 | $12K |
| Wells Fargo & Company | 0.00% | No change | 1 | $14 |
"% of holder's portfolio" is FTXH's weight in each manager's 13F, not the share of First Trust Nasdaq Pharmaceu the manager owns.